Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Jahnel, J; Zöhrer, E; Fischler, B; D'Antiga, L; Debray, D; Dezsofi, A; Haas, D; Hadzic, N; Jacquemin, E; Lamireau, T; Maggiore, G; McKiernan, PJ; Calvo, PL; Verkade, HJ; Hierro, L; McLin, V; Baumann, U; Gonzales, E.
Attempt to Determine the Prevalence of Two Inborn Errors of Primary Bile Acid Synthesis: Results of a European Survey.
J Pediatr Gastroenterol Nutr. 2017; 64(6):864-868
Web of Science PubMed FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Jahnel Jörg
Zöhrer Evelyn
Altmetrics:

Dimensions Citations:

Plum Analytics:
Abstract:
Inborn errors of primary bile acid (BA) synthesis are genetic cholestatic disorders leading to accumulation of atypical BA with deficiency of normal BA. Unless treated with primary BA, chronic liver disease usually progresses to cirrhosis and liver failure before adulthood. We sought to determine the prevalence of 2 common disorders, 3β-hydroxy-Δ-C27-steroid dehydrogenase (3β-HSD) and Δ-3-oxosteroid-5β-reductase (Δ-3-oxoR) deficiencies and to describe current diagnostic and treatment strategies among different European paediatric hepatology centres. A total of 52 clinical paediatric centres were approached and 39 centres in 21 countries agreed to participate in the Web-based survey. The survey comprised questions regarding general information, number of cases, diagnostic, and therapeutic management. Seventeen centres located in 11 countries reported patients with inborn errors in primary BA synthesis, 22 centres never had cases diagnosed. In total, we could identify 63 patients; 55 with 3β-HSD and 8 with Δ-3-oxoR deficiency in 21 countries. The minimum estimated combined prevalence of these diseases was 1.13 cases per 10 million (0.99 and 0.14 for 3β-HSD and Δ-3-oxoR deficiencies, respectively). The surveyed colleagues indicated their main challenges to be the rarity of diseases and the lack of convenient laboratory facilities nearby. We have identified the largest cohort of patients with 3β-HSD or Δ-3-oxoR deficiency described so far. These diseases are likely underdiagnosed mainly due to unawareness of their existence and the lack of laboratory facilities.
Find related publications in this database (using NLM MeSH Indexing)
Adrenal Hyperplasia, Congenital - diagnosis
Adrenal Hyperplasia, Congenital - epidemiology
Adrenal Hyperplasia, Congenital - therapy
Europe - epidemiology
Health Surveys -
Humans -
Oxidoreductases - deficiency
Prevalence -
Steroid Metabolism, Inborn Errors - diagnosis
Steroid Metabolism, Inborn Errors - epidemiology
Steroid Metabolism, Inborn Errors - therapy

Find related publications in this database (Keywords)
AKR1D1
3 beta-hydroxy-Delta(5)-C-27-steroid
dehydrogenase
chenodeoxycholic acid
cholic acid
Delta(4)-3-oxosteroid-5 beta-reductase
HSD3B7
© Meduni Graz Impressum